Drug Shortage Report for SANDOZ MOMETASONE
Report ID | 176059 |
Drug Identification Number | 02449811 |
Brand name | SANDOZ MOMETASONE |
Common or Proper name | MOMETASONE |
Company Name | SANDOZ CANADA INCORPORATED |
Market Status | MARKETED |
Active Ingredient(s) | MOMETASONE FUROATE |
Strength(s) | 50MCG |
Dosage form(s) | SPRAY, METERED DOSE |
Route of administration | NASAL NASAL |
Packaging size | 140DOS |
ATC code | R01AD |
ATC description | DECONGESTANTS AND OTHER NASAL PREP.FOR TOPICAL USE |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2022-11-28 |
Estimated end date | 2022-12-16 |
Actual end date | 2022-12-07 |
Shortage status | Resolved |
Updated date | 2022-12-12 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2022-12-12 | French | Compare |
v4 | 2022-12-12 | English | Compare |
v3 | 2022-11-29 | English | Compare |
v2 | 2022-11-28 | French | Compare |
v1 | 2022-11-28 | English | Compare |
Showing 1 to 5 of 5